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Delta-like 1 homolog (Dlk1) is important in myogenesis. However, the roles of different Dlk1
isoforms have not been investigated. In C2C12 cell lines producing different Dlk1 isoforms,
membrane-bound Dlk1 promoted the hypertrophic phenotype and a higher fusion rate, whereas
soluble Dlk1 inhibited myotube formation. Inversed expression patterns of genes related to
myogenic differentiation further support these phenotypic changes. In addition, temporal
expression and balance between the Dlk1 isoforms have a regulatory role in myogenesis in vivo.
Collectively, Dlk1 isoforms have distinctive effects on myogenesis, and its regulation during
myogenesis is critical for normal muscle development.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction DLK1 is a glycoprotein consisting of six EGF-like domains, aMyoblasts undergo proliferation followed by differentiation
into mononucleated myocytes to form the myotube by fusing to
each other or to an existing myotube. The balance between differ-
entiation and reserving the myoblast is important for maintaining
muscle mass. Four myogenic regulatory factors (MRFs), myogenic
differentiation (MyoD), myogenic factor 5 (Myf5), myogenin
(Myog), and Mrf4, and the inhibitory factors paired box 7 (Pax7),
Notch, and bone morphogenetic protein 4 (Bmp4), are known to
regulate this balance [1–9].
Delta-like 1 homolog (DLK1) is considered to be a candidate
gene causing muscle hypertrophy in callipyge sheep, and over-
expression of sheep DLK1-C2 in a transgenic mouse model had
the same effect of increasing muscle mass [10–12]. Full-lengthprotease-sensitive juxtamembrane domain, and a transmem-
brane domain. In the mouse, there are several splicing isoforms
of Dlk1 mRNA, and the resulting protein isoforms can be
distinguished by whether the resulting juxtamembrane domain
is retained or not [13,14]. The A and B isoforms have the
juxtamembrane domain and can produce the soluble form of
Dlk1 after being cleaved by a tumor necrosis factor-alpha
converting enzyme (TACE) [15]. The other forms without juxta-
membrane domain, C, C2, D, and D2, are not cleaved and remain
on the cell membrane [14]. The number of alternative splicing
isoforms of Dlk1 varies among species, and expression levels
and patterns of the alternative splicing isoforms are altered
depending on the development stage and age [10,11,16–19].
Dlk1-null mice have a phenotype of growth retardation, obesity,
and skeletal malformation, whereas overexpression of soluble
Dlk1 causes inhibition of preadipocyte differentiation and meta-
bolic abnormality [20,21]. Notably, recent studies showed the
critical role of Dlk1 in myogenesis and muscle regeneration
[22–24].
Although Dlk1 has been found in several isoforms and cleavage
products in vivo, the function of these isoforms in regulating
myogenesis has not been studied. In this study, the function of
representative mouse Dlk1 isoforms in muscle development
were investigated in C2C12 cells, using 6 EFG as a soluble
Dlk1, C2 form as a membrane-bound Dlk1, and A form as an
intermediate form.
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2.1. Vector construction
The coding sequences of mouse Dlk1-A and -C2 isoforms were
ampliﬁed from mouse cDNA by PCR with the primer set mDlk1-F
and mDlk1-R (Suppl. Table 1) and cloned into the pQCXIP retroviral
vector (Clontech, Mountain View, CA). Vectors containing hemag-
glutinin (HA)-tagged Dlk1 were constructed by adding HA-tag
sequences at the 30 end using PCR with a mDlk1-R-HA primer [25].
The 6 epidermal growth factor (EGF) with a C-terminal HA-tag was
ampliﬁed by PCR with the primer set mDlk1-F and 6EGF-R-HA and
was cloned into the pQCXIP vector. The pQCXIP retroviral vectors
containing no gene (empty vector, EV) or each isoform of Dlk1were
used to produce the retrovirus for infecting the C2C12 cells.
2.2. C2C12 cell line establishment and culture
The C2C12 mouse myoblast line (ATCC, Manassas, VA) was
maintained with DMEM (Gibco, Grand Island, NY) containing 10%
FBS (Gibco) and 1 penicillin–streptomycin (Gibco). To establish
cell lines for control or expressing the Dlk1 isoforms, C2C12 cells
were infected by retroviruses encoding no gene (EV) or each Dlk1
isoform, and subjected to selection with 2.5 lg/ml of puromycin
(Clontech) for 10 days by subculturing before conﬂuency. For dif-
ferentiation, when the cells reached 90% conﬂuence the medium
was replaced with a differentiation medium containing 2% horse
serum (Gibco) in DMEM. Half of the medium was replaced with
fresh differentiation medium every 2 days.
2.3. Animals
All animal procedures were approved by the Institutional Ani-
mal Care and Use Committee (IACUC) at The Ohio State University.
Muscle tissues were collected from fetuses of the ICR (CD-1) out-
bred line (Harlan Laboratories, Indianapolis, IN) from 14 to 18 days
post coitum and from neonates 1, 5, 10, and 15 days after birth
(n = 5 per group). Pelvic limb muscle was collected from three
150-day-old normal (NormalMat/NormalPat) and three callipyge
(NormalMat/CLPGPat) sheep.
2.4. RNA isolation and reverse-transcription quantitative
PCR (RT-qPCR)
Total RNAs were isolated from C2C12 cells as well as mouse and
sheep muscle using Trizol (Invitrogen, Carlsbad, CA), and used for
cDNA synthesis with the Moloney murine leukemia virus reverse
transcriptase (Invitrogen). The reverse-transcription quantitative
PCR (RT-qPCR) primer sets (Suppl. Table 2) for analyzing gene
expression were conﬁrmed by PCR before conducting RT-qPCR.
Measured Ct values were used to calculate the relative expression
level of the target genes using the comparative 2DDCt method
[26]. Cyclophilin B was used as an internal control, and the mean
Ct of EV on day 0 was used for calculating the fold changes. To ana-
lyze the expression patterns of alternative splicing forms of the
Dlk1 gene in mouse muscle tissues, semi-quantitative RT-PCR
was performed with the Dlk1 primer set mDLK1-4 E/F and
mDLK-SP-R2, and the ribosomal protein, large, P0 (Rplp0) gene
was ampliﬁed for reference by using the primer set Rplp0-F and
Rplp0-R (Suppl. Table 1).
2.5. Immunoblotting
Protein preparation and immunobloting procedures were
conducted as described in our previous report [27]. Anti-DLK(C-19; 1:20, Santa Cruz Biotechnology, Santa Cruz, CA), anti-DLK
(A-17; 1:1000, Santa Cruz Biotechnology), and anti-HA-tag (6E2;
1:3000, Cell Signaling Technology, Danvers, MA) antibodies were
used as primary antibodies, and HRP-conjugated bovine anti-goat
IgG (1:2000, Jackson ImmunoResearch Laboratories, West Grove,
PA) and horse anti-mouse IgG (1:5000, Cell Signaling Technology)
antibodies were used as secondary antibodies.
2.6. Immunostaining and quantiﬁcation of length, thickness, and
fusion rate of myotubes
Immunostaining of cells was performed as described previously
with modiﬁcation [28]. Anti-myosin heavy chain antibody (H-300;
1:200, Santa Cruz Biotechnology) was used as a primary antibody,
and FITC-conjugated donkey anti-rabbit IgG (1:400, Jackson Immu-
noResearch Laboratories) was used as a secondary antibody. The
nuclei of cells were stained with 40,6-diamidino-2-phenylindole
(DAPI, Invitrogen). Images were taken using a ﬂuorescence micro-
scope equipped with a QImaging Micropublisher 5.0 CCD camera
(QImaging, Burnaby, BC, Canada). The length, thickness, and fusion
rate of myotubes were measured with three randomly selected
images by using the ImageJ program (NIH, Bethesda, MD). Fusion
rate was determined by dividing the number of nuclei in myotubes
by the total number of nuclei.
2.7. Statistical analysis
Results are presented as mean and standard error of means.
Comparisons between the Dlk1 forms were performed by using
the one-way analysis of variance in each day, followed by Tukey’s
honestly signiﬁcant difference test for multiple comparisons at the
signiﬁcance level (alpha = 0.05).
3. Results
3.1. Dlk1 isoform expression and cleavage in C2C12 cells
Four stable C2C12 cell lines were generated by infecting the ret-
roviruses encoding no gene (EV), the Dlk1-A for production of both
membrane-bound and soluble Dlk1, the Dlk1-C2 for the mem-
brane-bound form, or the 6 EGF form for soluble Dlk1 (Fig. 1A)
[14]. The endogenous Dlk1 was barely detectable in EV-transfected
cells, indicating very low levels of endogenous Dlk1 expression in
the C2C12 cell line [23]. Two bands corresponding to around
50 kDa in the lane for the Dlk1-A form resulted from glycosylated
and non-glycosylated forms of Dlk1-A protein (Fig. 1B). Unexpect-
edly, the Dlk1-C2 form, that reportedly did not undergo cleavage in
3T3-L1 adipocytes, can be cleaved in the C2C12 cells (Fig. 1B).
Cleavage of Dlk1-C2, which has an HA-tag at the C-terminal end
(intracellular), was conﬁrmed with two antibodies, anti-DLK C-ter-
minal antibody (C-19) and anti-HA-tag antibody for the cell lysate,
and an anti-DLK N-terminal antibody (A-17) for the medium. It
was further conﬁrmed in other cell types, 3T3-L1 and HEK-293
cells, and even the A form with deletion of the juxtamembrane do-
main [25] was also revealed to be cleaved (Suppl. Fig. 1). Detection
of the cleaved C-terminal residues (about 12 kDa) in the cell lysates
and secreted soluble Dlk1 in the media of both Dlk1-A and -C2 cells
clearly demonstrates the cleavage of the two proteins. However,
relative amounts of the cleaved C-terminal and secreted extracel-
lular domain from the C2 form were less than those observed for
the A form (Fig. 1B and Suppl. Fig. 1). These important ﬁndings
led us to consider that Dlk1-A is an intermediate form producing
both soluble and membrane-bound Dlk1, while the majority of
C2 form may remain as membrane-bound Dlk1 during myogenic
differentiation.
Fig. 1. Representative isoforms of Dlk1 and conﬁrmation of overexpression and cleavage in C2C12 cell lines. (A) Representative isoforms of Dlk1. Dlk1 has several alternative
splicing forms and the cognate proteins are known to be proteolytically cleaved or not depending on the forms. The A form can be either bound to the membrane or cleaved to
produce 6 EGF while the C2 form can only be anchored on the membrane as it has no protease-sensitive juxtamembrane domain (White oval: EGF domain, gray rectangular:
protease-sensitive juxtamembrane domain, and black rectangular: transmembrane domain). (B) Expression and cleavage of Dlk1 in C2C12 cell lines. The Dlk1-A form was
cleaved as expected, but also the C2 form was cleaved. The cleavage of Dlk1-A and -C2 isoforms was conﬁrmed by using anti-Dlk1 (upper left) and anti-HA-tag (upper center
and right) antibodies. The overexpression of 6 EGF in C2C12 cells was also conﬁrmed by anti-HA tag antibody (lower left). The soluble Dlk1 derived from the A and C2 forms
after cleavage, and 6 EGF, were detected in the medium using antibodies recognizing an amino-terminal proximal region of the protein or the HA tag, respectively (lower
right).
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membrane-bound form increases the thickness of myotubes
Formation of myotubes was signiﬁcantly affected by Dlk1 iso-
forms (Fig. 2A). The myotubes of the cells expressing the EV and
C2-form cells were signiﬁcantly longer than seen with expression
of the A-form or 6 EGF (Fig. 2B; P < 0.001), indicating that the pres-
ence of soluble Dlk1 decreases myotube length. The thickness of
myotubeswas increased by C2-form (Fig. 2C; P < 0.001). An analysis
of the average number of nuclei in the myotube revealed that the
cells expressing the C2-form had signiﬁcantly more nuclei than in
the other groups, while the 6 EGF cells had the least number of nu-
clei (Fig. 2D). In addition, analysis of fusion rates revealed that the
C2-form cells had the greatest fusion rate, followed by A-form with
similar numbers in EV control and 6 EGF cells (Fig. 2E; P < 0.001).
Overall, soluble Dlk1 inhibited myotube formation, while mem-
brane-bound Dlk1 led to development of a hypertrophic phenotype.
3.3. Genes inducing myogenic differentiation are differently regulated
by the Dlk1 isoforms
To analyze how Dlk1 isoforms affect myogenesis, relative
expression of the genes related to myogenesis was measured(Fig. 3). Pax7 was expressed approximately 2-fold higher before
differentiation and 4-fold higher during differentiation in the 6
EGF cell than in the other groups (Fig. 3A). Myf5 expression was
2-fold higher in the C2-form cells than in the 6 EGF cells before dif-
ferentiation (Fig. 3B). MyoD expression was higher in the C2-form
cells than in the 6 EGF cells at day 1 and greater in A- and C2-form
cells than in EV and 6 EGF cells at day 4 (Fig. 3C). Myog increased
continuously during differentiation, but decreased signiﬁcantly
only in 6 EGF cells at day 4 (Fig. 3D).
3.4. Genes regulated by membrane-bound Dlk1s to induce
a hypertrophic phenotype and inhibition of differentiation
by the soluble form
Expression of several genes related to muscle hypertrophy was
analyzed to identify mediators of Dlk1. As shown in Fig. 4A, expres-
sion of myostatin (Mstn) increased dramatically about 30-fold in
the EV cells at day 4 compared to day 0, while the other cells main-
tained Mstn expression at basal levels (P < 0.05). Follistatin (Fst)
was down-regulated in 6 EGF cells compared to the other groups,
whereas it was up-regulated in C2-form cells at day 4 (Fig. 4B;
P < 0.05). Expression of Caveolin 3 (Cav3), an essential factor for
myocyte fusion, was increased during differentiation in all groups,
Fig. 2. Differentiation of C2C12 cells expressing different isoforms of Dlk1 and characterization of myotubes. (A) The C2C12 cells expressing different forms of Dlk1 or no Dlk1
(EV for empty vector not encoding Dlk1, A for A-form of Dlk1, C2 for C2-form of Dlk1, and 6 EGF for soluble form of Dlk1) were differentiated for 6 days. Cells were stained
with DAPI (upper panels) and anti-myosin heavy chain antibody (lower panels; magniﬁcation = 35). (B–E) The length and thickness of ﬁbers, nuclei per myotube, and fusion
rate were determined for each Dlk1 form. The unit of length is arbitrary based on the measured pixels (n = 3). The letters on the top of bars were determined by Tukey’s HSD
test (alpha = 0.05) and the bars with the same letter are not signiﬁcantly different.
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than in 6 EGF cells at day 4 (Fig. 4C). Cav3 was suppressed in the
groups producing soluble Dlk1, but was not affected by mem-
brane-bound Dlk1 as compared to the EV. The expression of
Bmp4, an inhibitor of myocyte differentiation, was down-regulated
by A- and C2 forms during day 0–2, but up-regulated by 6 EGF dur-
ing day 1–2 (Fig. 5A). Expression of Noggin (Nog), an antagonist of
BMP, was greater in the C2- and A-form cells than in the EV and 6
EGF cells before and during differentiation (Fig. 5B), indicating up-
regulation of Nog by membrane-bound Dlk1. Lastly, the expression
of genes involved in atrophy/dystrophy, including Atrogin1, mus-
cle-speciﬁc RING ﬁnger protein 1 (Murf1), forkhead box O3 (Foxo3),and Dystrophin, was not signiﬁcantly different among the groups
(Fig. 5C–F), suggesting that signals related to muscle wasting
may not be related to changes in myotube formation in response
to Dlk1 isoforms.
3.5. The regulation of Dlk1 gene expression and cleavage of the protein
is important for normal development of muscle in vivo
Analysis of alternative splicing patterns of Dlk1 mRNA revealed
that the primarily expressed Dlk1 isoforms were A and C2 during
muscle development in mice (Fig. 6A). The A form was expressed
more abundantly than the C2 form throughout the time points.
Fig. 3. The expression of myogenic genes. The expression of the myogenic factors Pax7 (A), Myf5 (B), MyoD (C), and Myog (D), were determined on day 0, 1, 2 and 4 of
differentiation by using RT-qPCR (n = 3). ⁄, ⁄⁄, and ⁄⁄⁄ indicate signiﬁcance levels of P < 0.05, P < 0.01, and P < 0.001, respectively. The bars with the same letter are not
signiﬁcantly different within the day.
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day 5 after birth, but they were dramatically reduced after day 5.
Immunobloting analysis (Fig. 6B) showed that three major bands
of membrane-bound Dlk1 were as expected detected in mouse
muscle, as reported in the previous study [20]. The level of total
membrane-bound Dlk1 protein continuously decreased after birth
(P < 0.001; Fig. 6B and C). Dlk1-A was a major form of membrane-
bound Dlk1 at embryonic day 17; however, it decreased more rap-
idly than Dlk1-C2 and became a minor form at day 5 after birth
(Fig. 6C). Cleavage of Dlk1 protein also decreased continuously
after birth and was barely detectable at day 10 after birth
(P < 0.001; Fig. 6B and D). The ratio of membrane-bound Dlk1 to
cleaved Dlk1 was increased signiﬁcantly on day 10 (P < 0.001;
Fig. 6B and E). This indicates that the cleavage of Dlk1 protein is de-
creased, and the relative amount of membrane-bound Dlk1 is
increased.
Abnormally high expression of DLK1-C2 isoform is responsible
for muscle hypertrophy of callipyge sheep [11,19], which was also
conﬁrmed by about 30-fold greater expression level of DLK1 in the
muscle of callipyge sheep compared to normal sheep (P < 0.05;
Fig. 6F). The expression patterns of several genes, including MSTN,
BMP4 and PAX7, were similar to the results obtained from the
C2C12 cell overexpressing Dlk1-C2 (Fig. 6G). Overall, the expres-
sion pattern of downstream genes regulated by membrane-bound
DLK1 in vivo was similar to that observed in vitro.
4. Discussion
Unlike the 3T3-L1 cells expressing endogenous Dlk1, the C2C12
cells having undetectable levels of Dlk1, as reported by anothergroup [23], could serve as an excellent in vitro system to study
the function of exogenously expressed Dlk1 isoforms. Although
Dlk1-C2 form was known not to be cleaved [14], our immunoblot-
ting analysis using several different antibodies clearly demon-
strated that Dlk1-C2 is cleaved and generates a soluble Dlk1 in
C2C12, 3T3-L1, and HEK-293 cells. Moreover, the Dlk1-dA, Dlk1-
A without the juxtamembrane domain, could also be cleaved at a
detectable level and generate the soluble form (Suppl. Fig. 1). These
data suggest that the Dlk1 isoforms without the juxtamembrane
domain can be noticeably cleaved. However, it was not determined
which protease, including TACE, could cleave the Dlk1 isofoms
without the juxtamembrane domain. Due to the fact that the
majority of the C2 form remained intact, it was considered a major
membrane-bound Dlk1 in this study, with the A form representing
an intermediate form.
The most important ﬁnding in this study is that membrane-
bound Dlk1 promotes hypertrophic myotube formation, whereas
soluble Dlk1 inhibits myotube formation. The thicker myotubes
with greater fusion rates generated by membrane-bound Dlk1
may be mediated by up-regulation of myogenic transcription
factors (Myf5, MyoD, and Myog), genes promoting hypertrophy
(Fst and Nog), and down-regulation of anti-myogenic genes
(Mstn and Bmp4). In addition, the expression pattern of the
genes Mstn, Bmp4, and Pax7, in the hypertrophic muscle of cal-
lipyge sheep, caused by an abnormally high expression of the
DLK1-C2 as a major form [11], was very similar to that of
C2C12 cells expressing Dlk1-C2. Considering the similar pheno-
type of muscle and expression patterns of genes between calli-
pyge sheep and C2C12 cells expressing Dlk1-C2, the membrane-
bound form is likely to induce hypertrophy in muscle. This is
Fig. 4. The expression of genes related to muscle hypertrophy. The expression of genes known to inhibit or induce muscle hypertrophy, Mstn (A), Fst (B), and Cav3 (C), were
determined on days 0, 1, 2 and 4 of differentiation by using RT-qPCR (n = 3). ⁄ and ⁄⁄ indicate signiﬁcance levels of P < 0.05 and P < 0.01, respectively. The bars with the same
letter are not signiﬁcantly different within the day.
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in transgenic mice overexpressing sheep DLK1-C2 in the skeletal
muscle [11].
The inhibitory roles of soluble Dlk1 in myogenesis was accom-
panied by the down-regulation of myogenic transcription factors
(Myf5, MyoD, and Myog) and up-regulation of genes (Pax7, and
Bmp4) inhibiting the differentiation and sparing the myoblasts
during differentiation. Especially increased Bmp4 expression and
reduced expression of Nog, an antagonist of BMP, by soluble
Dlk1 could contribute to inhibiting myogenic differentiation [9],
suggesting Bmp4 might be an effective mediator of soluble Dlk1.
The down-regulation of Cav3, an essential factor for myocyte
fusion, by soluble Dlk1, could be associated with short myotubes.
Taken together, dramatically up-regulated Pax7 and Bmp4 and
down-regulation of Myf5 and MyoD indicate that soluble Dlk1
could halt the myogenic process at early stages, possibly leading
to maintaining more myogenic progenitor cells. Soluble Dlk1
seems to have a general inhibitory effect on cellular differentia-
tion, including adipocyte differentiation, the differentiation of
myocytes into adipocytes, mesenchymal stem cells into adipo-
cytes and osteoblasts, and chondrogenic cell differentiation
[14,25,29–32].
During perinatal ages in mice, total amounts of Dlk1 were grad-
ually reduced, but the cleavage of Dlk1 protein was dramatically
decreased, resulting in an increased ratio of membrane-bound to
soluble Dlk1 in postnatal muscle tissues. Both membrane-bound
and soluble Dlk1 abundantly found during the embryonic ages
may have a role in balancing between differentiation andmaintenance of myogenic precursor cells, respectively. However,
increasing ratios of membrane-bound to soluble form after birth
may promote differentiation of myogenic cells and maturation of
myoﬁbers, which is associated with the acquisition of physical
ability of muscle. The switching of Dlk1 forms in vivo may occur
through two different mechanisms; regulation of Dlk1 isoform
expression and protease shedding of Dlk1 proteins. Because mice,
cattle, sheep, and pigs have two or more alternative splicing
isoforms of Dlk1 [11,13,19], they would use both mechanisms to
regulate ratios of membrane-bound to soluble DLK1. However,
in humans and birds expressing only a full-length Dlk1 [16,18],
the regulation of DLK1 shedding may be a more important
mechanism for switching DLK1 forms. Taken together, temporal
expression of Dlk1 during embryonic and neonatal ages should
be tightly regulated for normal muscle development and
maturation.
Abnormal muscle development in maternal or paternal unipa-
rental disomy (m/pUPD) chromosome 12 is known to be caused
by dysregulation of Dlk1 expression [33,34], suggesting the impor-
tance of Dlk1 regulation in myogenesis. The absence of Dlk1
expression in mouse mUPD12 fetus resulted in premature muscle
formation and fewer numbers of muscle ﬁbers, leading to hypoto-
nia in neonates [35,36]. Considering the given negative inﬂuence of
soluble Dlk1 on myogenic differentiation and positive inﬂuence of
membrane-bound Dlk1 on myoﬁber formation, it is possible that
premature muscle in the mUPD12 fetus could be caused by the ab-
sence of soluble Dlk1 and fewer numbers of myoﬁbers by the ab-
sence of membrane-bound Dlk1. In support of this explanation,
Fig. 5. The expression of genes related to inhibition of myogenic differentiation and muscle wasting. The expression of Bmp4 (A), which is known to inhibit myogenic
differentiation, and its antagonist (Nog; B), as well as expression of Atrogin1 (C), Murf-1 (D), Foxo3 (E), and Dystrophin (F), which are known to be related to muscle atrophy/
dystrophy, were determined on days 0, 1, 2 and 4 of differentiation by using RT-qPCR (n = 3). ⁄, ⁄⁄, and ⁄⁄⁄ indicate signiﬁcance levels of P < 0.05, P < 0.01, and P < 0.001,
respectively. The bars with the same letter are not signiﬁcantly different within the day.
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delayed muscle maturation and higher ﬁber numbers [36],
which are likely caused by abnormally high amounts of soluble
and membrane-bound Dlk1, respectively. Our ﬁndings from the
current studies provide a basis to explain distinct phenotypic
differences in muscle development of mUPD12 and pUPD12
fetuses.
In conclusion, different forms of Dlk1 have distinctive effects on
myogenesis. Membrane-bound Dlk1 enhances myotube formation
and hypertrophy, while soluble Dlk1 inhibits myocyte differentia-
tion and myotube formation, demonstrating that the regulation of
Dlk1 isoforms during myogenesis is critical for normal muscle
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Fig. 6. Dlk1 isoform expression and proteolytic cleavage in muscle of mice and callipyge sheep. (A) The expression of the Dlk1 gene during mouse muscle development from
14 to 18 days post coitum and 1, 5, 10, and 15 days after birth. Mainly Dlk1-A and C2 isoforms were ampliﬁed by PCR in mouse muscle. However, the expression levels were
decreased 10 days after birth. The Rplp0 gene was used for reference. (B) The expression level and cleavage of Dlk1 protein during mouse muscle development from 17 days
post coitum and 1, 5, and 10 days after birth. Total protein concentrations were determined by Coomassie staining. (C–E) Quantiﬁcation of Dlk1 protein expression from panel
B. Each Dlk1 band was normalized by using the Coomassie staining result. Among the membrane-bound Dlk1 forms, the A and C2 forms were distinguishable by using C2C12
cells overexpressing the A and C2 form as positive controls. The ratio of membrane-bound to cleaved Dlk1 was determined. The bars with the same letter are not signiﬁcantly
different. (F and G) The expression of Dlk1 and important genes related to induction of muscle hypertrophy or inhibition of differentiation were analyzed in the adult pelvic
limb muscle of normal sheep (n = 3) vs. callipyge sheep (n = 3) at the age of 150 days. Asterisk indicates a signiﬁcance level of P < 0.05.
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